August 15, 2017 Tom Lin, MD, PhD Lin Bioscience 12F., No. 68, Sec 5, Zhongxiao E. Road, Xinyi Dist., Taipei City 110, Taiwan (R.O.C.) RE: Amendment to the Exclusive Licnese Agreement between Lin Bioscience, Inc. (“Company”) and The Trustees of...Exclusive License Agreement • April 5th, 2022 • Belite Bio, Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 5th, 2022 Company Industry JurisdictionThe above referenced Exclusive License Agreement (“Agreement”) entered into by the Trustees of Columbia University in the City of New York (“Columbia”) and Lin Bioscience,Inc. (“Company”), dated as of September 13, 2016, is hereby amended, pursuant to Section 22 of the Agreement, as follows:
August 15, 2017 Tom Lin, MD, PhD Lin Bioscience 12F., No. 68, Sec 5, Zhongxiao E. Road, Xinyi Dist., Taipei City 110, Taiwan (R.O.C.) RE: Amendment to the Exclusive Licnese Agreement between Lin Bioscience, Inc. (“Company”) and The Trustees of...Exclusive License Agreement • January 21st, 2022 • Belite Bio, Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 21st, 2022 Company Industry JurisdictionThe above referenced Exclusive License Agreement (“Agreement”) entered into by the Trustees of Columbia University in the City of New York (“Columbia”) and Lin Bioscience,Inc. (“Company”), dated as of September 13, 2016, is hereby amended, pursuant to Section 22 of the Agreement, as follows: